-The Economic Times My target for fulfilling Rajiv's vision has always been 2018. We can get there in less than 5 years if govt acts on our recommendations, says diplomat-turned-politician Mani Shankar Aiyar. You have been passionately talking about Panchayati Raj. But your party doesn't seem to share the same passion lately... Mani Shankar Aiyar: I don't agree with you here. The commitment of the party to Panchayati Raj and devolution of...
More »SEARCH RESULT
A suitable CAG -Ratna Viswanathan
-The Indian Express As the tenure of the incumbent draws to a close, let's debate the institution's structure and powers It is time for the selection of a new comptroller and auditor general as the tenure of the incumbent draws to a close on May 22. Traditionally, the CAG has been an unseen agency, churning out audit report after audit report on every department supported by government funds every year. The last...
More »Over 2,000 fewer farmers every day-P Sainath
-The Hindu The mistaken notion that the 53 per cent of India's population ‘dependent on agriculture' are all ‘farmers' leads many to dismiss the massive farmers' suicides as trivial There are nearly 15 million farmers (‘Main' cultivators) fewer than there were in 1991. Over 7.7 million less since 2001, as the latest Census data show. On average, that's about 2,035 farmers losing ‘Main Cultivator' status every single day for the last 20...
More »Abetment to suicide charge looms on Sen
-The Telegraph Kolkata: The Special Investigation Team (SIT) set up by the chief minister has asked district superintendents of police to initiate against Sudipta Sen cases of abetting the suicide of depositors. The SIT, led by director-general of police Naparajit Mukherjee, held a meeting today to discuss the strategy to pin down the Saradha Group chief for masterminding the default crisis that allegedly led five depositors to commit suicide in the districts. "Other...
More »Strong medicine for poor countries-Nayanima Basu
-The Business Standard The Novartis verdict by the Supreme Court emphasised the importance of flexibilities in drug patent laws, in contrast to Western countries which are seeking TRIPS-plus hardening through free-trade agreements As curtains on the six-year-long legal tussle with Swiss drug giant Novartis AG finally came down earlier this month, the Indian government did not waste a second in hailing the Indian patent law which it said was in "full...
More »